clinical_trials
Cutaneous Sarcoidosis Could Soon Get an Effective Therapy
Confidence86·multiple reportsImportance88NP-EVT-20261110-97901C2
(MedPage Today) -- ORLANDO -- Patients with cutaneous sarcoidosis -- a condition with no very effective therapy -- saw dramatic improvement with the dual-acting TYK2/JAK1 inhibitor brepocitinib (Lisraya) in a small phase II trial. Patients...
Read the original at the primary source
Cutaneous Sarcoidosis Could Soon Get an Effective Therapy
11/10/2026, 6:15:00 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —